Stay updated with breaking news from Illness Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Recent research highlighted the potential role of an atypical antipsychotic to treat anxiety — a prevalent and undertreated symptom in BPD that comes without the typical metabolic side effects.
Data showed good news for safety and tolerability with mixed good news for efficacy.
This analysis explored the relationship between AS engagement by participants and changes in participant performance and symptom-severity measures.
The FDA has approved Qelbree for the treatment of ADHD in adults 18 years of age and older.
The FDA has approved Qelbree for the treatment of ADHD in adults 18 years of age and older.